Mereo BioPharma Group plc 20-F for FY2022
Mereo BioPharma Group plc (MREO)
20-F
2023-03-28
For: 2022-12-31
View Original
Added on
April 08, 2026
About this 20-F
Mereo BioPharma Group plc filed this 20-F on March 28, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- 34.2M GBP
- compared with net income of 12.73M GBP a year earlier
- Diluted EPS
- -0.06 GBP
- compared with -0.05 GBP a year earlier